Stock GMED GLOBUS MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Globus Medical, Inc.

Equities

GMED

US3795772082

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
67.11 USD +0.78% Intraday chart for Globus Medical, Inc. +1.96% +25.93%
May. 29 BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating MT
May. 20 Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 MT

Evolution of the average Target Price on Globus Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b31f24a25c0cfa257d4e7e877cf31.PP7dYK29OtgWQEMXr8lrBnpm9eZKCgUXZbSYUTb4WDE.b7uRKMPKWIpdDQZ18LElfDgDm74mfEFABt35ZAasP3NGqZchwP5OtjsFdw~cea8568a3c0a24f6da14ee0ed7b0bd71

Analyst Recommendations on Globus Medical, Inc.

BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating MT
Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 MT
Globus Medical Insider Sold Shares Worth $4,090,022, According to a Recent SEC Filing MT
Morgan Stanley Raises Price Target on Globus Medical to $67 From $57, Keeps Equalweight Rating MT
Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing MT
Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating MT
Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards MT
Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating MT
Truist Securities Raises Price Target on Globus Medical to $63 From 60, Maintains Hold Rating MT
BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60 MT
Truist Securities Adjusts Price Target on Globus Medical to $60 From $58, Keeps Hold Rating MT
Stifel Adjusts Globus Medical's Price Target to $64 From $61, Keeps Buy Rating MT
Investors keep their cool despite inflation data Our Logo
Truist Adjusts Price Target on Globus Medical to $58 From $53, Maintains Hold Rating MT
Canaccord Genuity Adjusts Globus Medical's Price Target to $71 From $67, Keeps Buy Rating MT
RBC Cuts Price Target on Globus Medical to $70 From $77, Keeps Outperform Rating MT
Morgan Stanley Cuts Price Target on Globus Medical to $53 From $60, Maintains Equalweight Rating MT
Truist Securities Adjusts Price Target on Globus Medical to $53 From $58, Maintains Hold Rating MT
Roth MKM Starts Globus Medical With Buy Rating, Price Target is $75 MT
Stifel Upgrades Globus Medical to Buy From Hold, Cuts Price Target to $61 From $65 MT
Wells Fargo Lowers Price Target on Globus Medical to $58 From $63, Maintains Equal-Weight Rating MT
Truist Securities Adjusts Price Target on Globus Medical to $65 From $68, Keeps Hold Rating MT
Barclays Raises Price Target on Globus Medical to $77 From $75, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on Globus Medical to $68 From $64, Maintains Hold Rating MT
Morgan Stanley Adjusts Globus Medical's Price Target to $60 From $64, Keeps Equalweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
67.11 USD
Average target price
71.17 USD
Spread / Average Target
+6.04%
High Price Target
85 USD
Spread / Highest target
+26.66%
Low Price Target
55 USD
Spread / Lowest Target
-18.05%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Globus Medical, Inc.

BTIG
Piper Sandler
Morgan Stanley
Barclays
Stifel Nicolaus
Truist Securities
Canaccord Genuity
RBC Capital Markets
Roth MKM
Wells Fargo Securities
BofA Securities
Loop Capital
Needham & Co.
Jefferies & Co.
Oppenheimer
UBS
Credit Suisse
Citigroup
SVB Leerink

Ratings for Globus Medical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GMED Stock
  4. Consensus Globus Medical, Inc.